Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Ulferts International Limited (1711.HK)
Wan Chai, HK
Ulferts International Limited operates as an investment holding company that specializes in the retail and wholesale distribution of furniture across Hong Kong. The company's comprehensive product line includes a wide variety of home furnishings such as mattresses, pillows, sofas, beds, cabinets, dining tables, chairs, wardrobes, coffee tables, sideboards, and other related accessories. These items are primarily offered under the Ulfenbo brand and are accessible through various channels, including Dormire specialty stores, an extensive network of independent dealers, dedicated Ulfenbo counters in department stores, temporary pop-up shops, and promotional roadshows. Furthermore, Ulferts provides space-saving furniture solutions via its 'at home' retail outlets. Beyond its consumer-facing operations, the company delivers specialized services to corporate clients, encompassing the planning, design, procurement, and installation of custom-made furniture. It also assists with group tenancy agency and acts as a liaison for project-based customers. As of March 31, 2022, Ulferts maintained a significant retail footprint, managing 28 points-of-sale under distinct brand names such as Ulferts Signature, Ulferts, at.home, Ulfenbo, Dormire, and Slumberland. Established in 1975 and headquartered in Wanchai, Hong Kong, Ulferts International Limited is a subsidiary of Ulferts International Group Holdings Limited.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +33.33% | +33.33% | +63.64% | +52.54% | +172.73% | -3.74% | -8.16% | -88.75% | -88.75% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
-
Revenue growth Specialty Retail: +6.4%-10.9% Q3'25: -25.5% (vs Q3'23)
-
EPS growth Specialty Retail: +20.6%-63.9% Q3'25: +71.1% (vs Q3'23)
-
FCF margin FCF growth · Specialty Retail: +29.3%-1.3% Q3'25: +3.6% (vs Q3'23)
-
EBIT margin Specialty Retail: +5.4%-22.6% Q3'25: -5.5% (vs Q3'23)
-
ROIC Specialty Retail: +6.5%-231.9% Q3'25: -204.0% (vs Q3'23)
-
Share dilution Specialty Retail: +0.1%+0.0% Q3'25: +0.0% (vs Q3'23)
-
Debt / EBITDA Net debt/EBITDA · Specialty Retail: 0.14×-2.34× Q3'25: -0.60× (vs Q3'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-27 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 2/5 |
| 2026-05-22 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-21 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-20 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-18 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-15 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-13 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-12 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-07 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-06 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-05 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-04 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-28 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-27 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-21 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-20 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-17 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Chuen Yin Chan | MD & Executive Director | 2M | male |
| Ching Loong Yeung | Executive Chairman | 133.0K | male |
| Man Seung Fan | Executive Director | 133.0K | female |
| Lai Yim Chan | Company Secretary | — | female |
| Man Ching Luk | Investor Relations Director | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 1711.HK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
